---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-001899"
form_type: "8-K"
ticker: "IRD"
cik: "0001228627"
company_name: "Opus Genetics, Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T10:28:01.326185+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Opus Genetics amends CEO and CFO employment agreements; enhances severance upon Change in Control

## Summary
- CEO Magrath severance multiple raised to 1.5x salary+target bonus on CIC termination; COBRA extended to 18 months.
- CFO Jhaveri severance multiple raised to 1.0x salary+target bonus; COBRA extended to 12 months.
- Magrath also gets prorated target bonus for non-CIC qualifying termination.
- Jhaveri's enhanced sever eligibility expanded to include 3 months prior to a Change in Control.

## SEC filing metadata
- accession: 0001140361-25-001899
- form_type: 8-K
- ticker: IRD
- cik: 0001228627
- company_name: Opus Genetics, Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1228627/000114036125001899/0001140361-25-001899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1228627/000114036125001899/ef20042243_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-001899
- JSON: https://secwatch.observer/filing/0001140361-25-001899.json
- Plain text: https://secwatch.observer/filing/0001140361-25-001899.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.